文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

动态驱动压与接受体外膜氧合的急性呼吸窘迫综合征患者死亡率相关

Dynamic driving pressure associated mortality in acute respiratory distress syndrome with extracorporeal membrane oxygenation.
PubMed 文献 · Ann Intensive Care · 2017-01-25
一句话结论严重ARDS接受ECMO患者中,ECMO启动后前3天平均动态驱动压较高与ICU死亡率独立相关。

该研究回顾了2006年5月至2015年10月因难治性低氧血症接受ECMO的158例严重ARDS患者,分析ECMO前后机械通气参数及生存相关因素。总体ICU死亡率为55.1%。ECMO启动后潮气量、峰值吸气压力和动态驱动压下降,而呼气末正压相对维持。Cox回归显示免疫抑制、APACHE II评分、ECMO前ARDS持续时间及ECMO第1至3天平均动态驱动压与ICU死亡率独立相关。

要点

  • ECMO启动后动态驱动压下降,但死亡者直至第7天动态驱动压均显著高于生存者。
  • ECMO第1至3天平均动态驱动压是ICU死亡的独立危险因素(HR 1.070;95%CI 1.026-1.116;P=0.002)。
  • 免疫抑制状态与ICU死亡独立相关(HR 1.957;95%CI 1.216-3.147;P=0.006)。
  • APACHE II评分越高(HR 1.039;95%CI 1.005-1.073;P=0.023)及ECMO前ARDS持续时间越长(HR 1.002;95%CI 1.000-1.003;P=0.029)与ICU死亡独立相关。
  • 该队列总体ICU死亡率为55.1%。

适用人群与场景

  • 因难治性低氧血症接受ECMO的严重ARDS患者,回顾性分析2006年5月至2015年10月病例。

处置流程与药物剂量

  • ECMO启动后潮气量、峰值吸气压力和动态驱动压下降,呼气末正压水平相对维持。

研究设计与关键结果

  • 回顾性研究,共纳入158例接受ECMO的严重ARDS患者,总体ICU死亡率为55.1%。
  • ECMO启动后,死亡者直至第7天动态驱动压均显著高于生存者。
  • Cox比例风险回归显示,免疫抑制(HR 1.957;95%CI 1.216-3.147;P=0.006)、APACHE II评分(HR 1.039;95%CI 1.005-1.073;P=0.023)、ECMO前ARDS持续时间(HR 1.002;95%CI 1.000-1.003;P=0.029)及ECMO第1至3天平均动态驱动压(HR 1.070;95%CI 1.026-1.116;P=0.002)与ICU死亡率独立相关。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于接受ECMO的严重ARDS患者,ECMO启动后前3天较高的平均动态驱动压与ICU死亡率独立相关,提示需关注该时段动态驱动压水平。
  • 免疫抑制状态、较高的APACHE II评分及ECMO前较长的ARDS持续时间与ICU死亡率独立相关,可能有助于风险分层。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The survival predictors and optimal mechanical ventilator settings in patients with severe acute respiratory distress syndrome (ARDS) undergoing extracorporeal membrane oxygenation (ECMO) are uncertain. This study was designed to investigate the influences of clinical variables and mechanical ventilation settings on the outcomes for severe ARDS patients receiving ECMO.

METHODS: We reviewed severe ARDS patients who received ECMO due to refractory hypoxemia from May 2006 to October 2015. Serial mechanical ventilator settings before and after ECMO and factors associated with survival were analyzed.

RESULTS: A total of 158 severe ARDS patients received ECMO were finally analyzed. Overall intensive care unit (ICU) mortality was 55.1%. After ECMO initiation, tidal volume, peak inspiratory pressure and dynamic driving pressure were decreased, while positive end-expiratory pressure levels were relative maintained. After ECMO initiation, nonsurvivors had significantly higher dynamic driving pressure until day 7 than survivors. Cox proportional hazards regression model revealed that immunocompromised [hazard ratio 1.957; 95% confidence interval (CI) 1.216-3.147; p = 0.006], Acute Physiology and Chronic Health Evaluation (APACHE) II score (hazard ratio 1.039; 95% CI 1.005-1.073; p = 0.023), ARDS duration before ECMO (hazard ratio 1.002; 95% CI 1.000-1.003; p = 0.029) and mean dynamic driving pressure from day 1 to 3 on ECMO (hazard ratio 1.070; 95% CI 1.026-1.116; p = 0.002) were independently associated with ICU mortality.

CONCLUSIONS: For severe ARDS patients receiving ECMO, immunocompromised status, APACHE II score and the duration of ARDS before ECMO initiation were significantly associated with ICU survival. Higher dynamic driving pressure during first 3 days of ECMO support was also independently associated with increased ICU mortality.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Chiu LC, Hu HC, Hung CY, et al. Dynamic driving pressure associated mortality in acute respiratory distress syndrome with extracorporeal membrane oxygenation. Ann Intensive Care. 2017. PMID: 28124234. doi:10.1186/s13613-017-0236-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。